Literature DB >> 25056934

2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission.

Hirofumi Mukai1, Shinzaburo Noguchi, Futoshi Akiyama, Hideo Inaji, Hirotaka Iwase, Jun Horiguchi, Junichi Kurebayashi, Koichi Hirata, Masakazu Toi, Masafumi Kurosumi, Norio Kohno, Reiki Nishimura, Seigo Nakamura, Shigeru Imoto, Takuji Iwase, Tokiko Endo, Toshiaki Saeki, Yasuhiro Ogawa, Yoshinori Ito, Yutaka Tokuda, Tadashi Ikeda.   

Abstract

Mesh：

Year:  2014        PMID： 25056934     DOI： 10.1007/s12282-014-0550-2

Source DB:  PubMed          Journal:  Breast Cancer        ISSN： 1340-6868            Impact factor:   4.239


× No keyword cloud information.
  4 in total

1.  Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women.

Authors:  Rena Yamazaki; Masafumi Inokuchi; Satoko Ishikawa; Subaru Myojo; Junpei Iwadare; Yukiko Bono; Yasunari Mizumoto; Mitsuhiro Nakamura; Masahiro Takakura; Takashi Iizuka; Tetsuo Ohta; Hiroshi Fujiwara
Journal:  Springerplus       Date:  2015-08-19

2.  The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient.

Authors:  Hiroji Iwata; Shigehira Saji; Masahiko Ikeda; Masashi Inokuchi; Takayoshi Uematsu; Tatsuya Toyama; Rie Horii; Chikako Yamauchi
Journal:  Breast Cancer       Date:  2019-11-22       Impact factor: 4.239

3.  Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Shin Yaogawa; Yasuhiro Ogawa; Shiho Morita-Tokuhiro; Akira Tsuzuki; Ryo Akima; Kenji Itoh; Kazuo Morio; Hiroaki Yasunami; Masahide Onogawa; Shinji Kariya; Munenobu Nogami; Akihito Nishioka; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2015-12-22       Impact factor: 6.639

Review 4.  Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.

Authors:  Marta Maes-Carballo; Isabel Muñoz-Núñez; Manuel Martín-Díaz; Luciano Mignini; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Health Expect       Date:  2020-08-03       Impact factor: 3.377
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.